ACE inhibitor or ARB to prevent kidney disease
Congratulations to PL editorial advisory board member, Dr. Craig Williams, PharmD, FNLA, BCPS, for his recent Pharmacotherapy editorial. It dispels the common belief that all diabetes patients with microalbuminuria need an ACE inhibitor or ARB, and complements our November 2012 article on the subject. Click here to view Dr. Williams' editorial.
Patients with diabetes do NOT necessarily benefit from an ACE inhibitor or ARB to prevent kidney disease.Most of us were taught that diabetes patients who spill small amounts of albumin in their urine should get an ACEI or ARB.
Current diabetes guidelines still recommend starting an ACEI or ARB for this MICROalbuminuria...even in patients without hypertension.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote